A trivalent vaccine, recombinant PcpA, PhtD and PlyD1, was effective in preventing pneumonia.
The trivalent vaccine induced protection of both infant and adult mice.
A reduction in Spn lung burden, in lung pathology, and secondary sepsis occurred.
An infant mouse challenge model that mirrors immune responses to human infants was used.